Tukaram Mundhe
Tracked across 7 events · 97 articles · First seen Jul 11, 2026 · Last active Aug 28, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: As FDA Commissioner, he announced and championed the order, reinforcing his role as a key regulator in Maharashtra's healthcare sector.
Aug 07, 2026 · 6 articles
Regulatory
Impact: As FDA Commissioner, he led the crackdown and publicly emphasized compliance, reinforcing his reputation as a strict regulator.
Aug 11, 2026 · 10 articles
Regulatory
Impact: As FDA Commissioner, he led the action and publicly emphasized patient safety and regulatory compliance.
Jul 11, 2026 · 8 articles
Regulatory
Impact: FDA Commissioner, responsible for implementing the directive and leading enforcement.
Aug 11, 2026 · 6 articles
Regulatory
Impact: As FDA Commissioner, Tukaram Mundhe publicly emphasised strict enforcement, which may bolster his reputation as a tough regulator. His statements signal continued vigilance in the pharmaceutical sector.
Aug 28, 2026 · 52 articles
Regulatory
Impact: As the head of the FDA, Tukaram Mundhe's aggressive enforcement policy is central to the dispute, though he is not directly a party.
Aug 10, 2026 · 6 articles
Regulatory
Impact: As FDA Commissioner, his enforcement drive has been criticized by the court for being overly aggressive, potentially affecting his reputation and the agency's approach.
Aug 11, 2026 · 9 articles
India — Maharashtra Food and Drug Administration
commissioner
↔
Tukaram Mundhe
Tukaram Mundhe serves as the Commissioner of the Maharashtra Food and Drug Admin
ERGEN INTELLIGENCE
Track Tukaram Mundhe live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard